Breast Implants and High Blood Pressure: Safety Considerations and Surgical Planning

Breast augmentation or reconstruction in women with hypertension requires careful preoperative assessment and perioperative management.

Key Considerations

  • BP Control: Surgery should be deferred until BP is stable (<140/90, ideally <130/80) on consistent regimen. Uncontrolled HTN increases perioperative cardiac events, bleeding, hematoma.
  • Medication Continuity: Continue antihypertensives perioperatively (except diuretics/ACEi/ARBs may be held morning of surgery per anesthesiologist). Beta-blockers, clonidine, calcium channel blockers—do not stop abruptly.
  • Implant Type: Saline vs. silicone gel—no direct BP effect. Choice based on aesthetics, rupture detection, patient preference.
  • Plane of Placement: Submuscular (dual plane) may cause more postoperative pain → sympathetic surge → BP elevation. Subglandular less dissection but higher capsular contracture risk. Discuss with surgeon.
  • Anesthesia: General anesthesia with controlled hemodynamics. Avoid ketamine (raises BP). Regional blocks (pecs, serratus) reduce opioid need.

Postoperative Monitoring

  • Vital signs q15–30 min in recovery; watch for pain-induced hypertension.
  • Multimodal analgesia (acetaminophen, gabapentinoid, limited opioids) to minimize sympathetic activation.
  • Early ambulation; DVT prophylaxis (sequential compression, ± chemoprophylaxis).

Long-Term

No evidence implants cause or worsen hypertension. Routine mammography requires Eklund displacement views. MRI screening for silent silicone rupture (FDA: 5–6 yr post-op, then q2–3 yr).

Decision Framework

Multidisciplinary: plastic surgeon + primary care/cardiology + anesthesiology. Shared decision-making weighing aesthetic goals vs. surgical risk. Most well-controlled hypertensive patients tolerate elective breast surgery well with proper optimization.

Hypertension - Related Articles